Adial Pharmaceuticals, Inc. (ADIL): Total Liabilities
$1.40M
As of 2025-12-31
$28.93M
As of 2026-06-30
-17.1%
3-year compound annual growth
-1.5%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.40M | +43.1% | 2026-03-05, Balance as of period end |
| 2024-12-31 | $975.9K | +49.4% | 2026-03-05, Balance as of period end |
| 2023-12-31 | $653.1K | -73.4% | 2025-03-04, Balance as of period end |
| 2022-12-31 | $2.46M | -38.1% | 2024-04-01, Balance as of period end |
| 2021-12-31 | $3.97M | +163.5% | 2023-03-30, Balance as of period end |
| 2020-12-31 | $1.51M | n/a | 2022-03-28, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Adial Pharmaceuticals, Inc. (ADIL) | 2025-12-31 | $1.40M | +43.1% |
| Kairos Pharma, Ltd. (KAPA) | 2024-12-31 | $992.0K | -67.4% |
| OS Therapies Inc (OSTX) | 2025-12-31 | $11.86M | +151.0% |
| Vyome Holdings, Inc (HIND) | 2025-12-31 | $2.74M | -52.6% |
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | $6.99M | +12.4% |
| CV Sciences, Inc. (CVSI) | 2025-12-31 | $5.49M | -10.4% |
| Cannapharmarx, Inc. (CPMD) | 2025-12-31 | $37.17M | +21.3% |
| GeoVax Labs, Inc. (GOVX) | 2025-12-31 | $2.52M | -19.0% |
| Matinas BioPharma Holdings, Inc. (MTNB) | 2025-12-31 | $2.38M | -52.9% |
Compare ADIL, KAPA, OSTX, HIND side by side · Screen every company in Pharmaceutical Preparations ↗